Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-033-2 | CAS number: 5235-82-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: OECD Guideline study performed in accordance with GLP requirements (but not a GLP study).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- This study is not designed to fulfill any testing guidelines. The current protocol is a streamlined version of OECD TG 492 test guideline.
- Deviations:
- no
- GLP compliance:
- no
- Remarks:
- The study was performed in accordance with GLP but was not reported under GLP due to lack of a GLP test lab for this assay
Test material
- Reference substance name:
- 4-[3-(1-naphthylamino)propyl]morpholine
- EC Number:
- 226-033-2
- EC Name:
- 4-[3-(1-naphthylamino)propyl]morpholine
- Cas Number:
- 5235-82-5
- Molecular formula:
- C17H22N2O
- IUPAC Name:
- N-[3-(morpholin-4-yl)propyl]naphthalen-1-amine
- Test material form:
- solid: granular
- Details on test material:
- Colour: Dark Brown to Black
GLP Characterized: January 21, 2016
Constituent 1
- Specific details on test material used for the study:
- Test Material Name: 4-(3-(1-naphthylamino)propyl)morpholine
Chemical Name: N-1-Naphthalenyl-4-morpholinepropanamine
Lot/Reference/Batch Number: ZA01212016
Purity/Characterization (Method of Analysis and Reference):
The purity of the test material was determined to be 94.4% by liquid chromatography with identification by nuclear magnetic resonance spectroscopy and liquid chromatography mass spectrometry (Ferrer, 2016a).
Test Material Stability Under Storage Conditions:
4-(3-(1-Naphthylamino)propyl)morpholine, lot ZA01212016, was determined to be stable for 2 weeks at 54°C which is equivalent to 24 months under ambient storage conditions as tested under USEPA OPPTS Guideline 830.6313 (Ferrer, 2016b).
Test animals / tissue source
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- The EpiOcular three-dimensional model has been extensively characterized and currently has an OECD test guideline (OECD TG 492) for identifying chemicals not requiring classification and labeling for eye irritation or serious eye damage.
The EpiOcular model estimates the potential ocular irritation of a test substance by measuring cytotoxicity following topical exposure (Freeman et al., 2010) (MatTek Corporation, Ashland, MA). This assay assumes that in vitro cytotoxicity is directly proportional to in vivo damage that a test substance would inflict upon exposure to the eye (cornea) (Jackson et al., 2006). This assumption is based in part on the Maurer et al. (2002) proposed hypothesis, which suggests that the level of ocular irritation is related to the extent of initial injury, regardless of the processes leading to tissue damage.
Principle of the Test System:
The EpiOcular model (OCL-200) uses Normal Human Epidermal Keratinocytes (NHEK) from a single donor as the cell source. The cells are cultured on polycarbonate membranes of cell culture inserts (MILLICELLs, 10 mm diameter, 0.6 cm² surface), in serum-free medium to form a multi-layered (5-8 cell layers), highly differentiated, stratified, squamous epithelia that closely mimics human eye (corneal) epithelium at biochemical and physiological levels. The EpiOcular tissue is mitotically and metabolically active and releases many of the pro-inflammatory agents (cytokines) that are important in ocular irritation and inflammation (Klausner et al., 2000).
Supplier and Location:
MatTek Corporation; Ashland Massachusetts
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- Preparation of the Test Material:
Test material was tested at a concentration of 100% (neat/as provided), following MatTek Corporation’s recommended procedure (Ocular Irritation Protocol: Neat Method-MTT ET-50).
Route of Administration:
The test material was administered by topical application to the ocular tissue.
Experiment Procedure:
Upon receipt, the EpiOcular tissue kits were stored at 2-8ºC and used within 24 to 48 hours of receipt from the supplier. On the day of testing, an aliquot of 0.9 mL of Dulbecco’s Modified Eagle’s medium (MatTek Corporation) was dispensed into the wells of 6-well plates. Each EpiOcular tissue was inspected for air bubbles between the agarose gel and Millicell insert prior to opening the sealed package. Tissue samples with air bubbles greater than 50% of the Millicell area were not used for testing.
The EpiOcular tissues were incubated at approximately 37ºC in a humidified atmosphere of approximately 5% CO2 for 60 ± 5 min. At the end of the first pre-incubation period, the inserts were transferred into wells containing fresh warm assay medium. The testing included treating the inserts with 50 μL (liquids) and of DPBS (negative control; 30±2 exposure time), 0.3% Triton X-100 (positive control; 30±2 exposure time) and 431-NAPM (30±2 min). Following the exposure periods, the EpiOcular tissues were carefully washed with Dulbecco phosphate buffered saline (DPBS; GIBCO, Grand Island, NY) (at least 5 times) to remove residual test substance. Following washes, the Millicell inserts were submerged in fresh assay media and incubated at 37ºC and 5% CO2 for approximately 12±2 minutes (to remove any test chemical absorbed into the tissue) at room temperature. Subsequently, the Millicell inserts were further incubated in fresh medium for 120±15 minutes at standard culture conditions (post-exposure incubation).
After incubation, the tissue inserts were transferred to a well containing 300 μL MTT solution in a 24-well plate and tissues were incubated for 3 ± 0.1 hr at standard cell culture conditions. After incubation the tissues were washed with DPBS and the MTT dye (formazan crystals) is solubilized and extracted from the inserts by incubating each insert in 2 mL of extract reagent (MatTek Corporation) for at least 2 hours with gentle shaking or overnight at room temperature. The extract solution was mixed and two x 200 μL aliquots of the extract solution was transferred to a 96-well plate and the optical density of the extracted formazan was quantified at 570 nm (OD570) using a Microplate Reader. - Duration of treatment / exposure:
- The testing included treating the inserts with 50 μL (liquids) and of DPBS (negative control; 30±2 exposure time), 0.3% Triton X-100 (positive control; 30±2 exposure time) and 431-NAPM (30±2 min).
- Duration of post- treatment incubation (in vitro):
- Following washes, the Millicell inserts were submerged in fresh assay media and incubated at 37ºC and 5% CO2 for approximately 12±2 minutes (to remove any test chemical absorbed into the tissue) at room temperature. Subsequently, the Millicell inserts were further incubated in fresh medium for 120±15 minutes at standard culture conditions (post-exposure incubation).
Results and discussion
In vitro
Results
- Irritation parameter:
- other: % Viability
- Value:
- 13.5
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- Criteria for Determination of a Valid Test:
The results for negative and positive controls met the assay acceptance criteria, suggesting appropriate conduct of the study.
1) The corrected mean OD570 value of the negative control tissues (exposed for 60 minutes) was 2.227 (i.e., ≥ 1.00; criteria set by the tissue manufacturer).
2) The mean tissue viability of the positive control was 1.0% (50% (relative to the negative control).
Assessment of Direct Test Chemical Reduction of MTT:
One limitation of this assay method is a possible interference of the test material with the MTT assay. A colored test substance or one that directly reduces MTT (and thereby mimics dehydrogenase activity of the cellular mitochondria) may interfere with the MTT end-point. This issue arises for test materials that remain on the tissue after several postexposure washes. In the present study, 4-(3-(1-naphthylamino)propyl)morpholine was evaluated for potential interaction with the MTT dye.
Approximately 100 mg of 431-NAPM was added to 1 mL of MTT solution in a tube and the mixture was incubated in the dark in an incubator with shaking at approximately 37°C for one hour. A negative control (100 μL of DPBS) was tested concurrently. Results from this experiment suggested that 431-NAPM did not interfere with the MTT dye, as the test material did not turn MTT solution to blue/purple crystals.
Applicant's summary and conclusion
- Interpretation of results:
- other: UN GHS Category 1 or 2
- Conclusions:
- The percent viability of 4-(3-(1-naphthylamino)propyl)morpholine and positive control were 13.5% and 1.0% respectively. As the percent cell viability of 4-(3-(1- naphthylamino)propyl)morpholine was ≤60%, 431-NAPM was classified as a potential irritant to eye.
- Executive summary:
4-(3-(1-naphthylamino)propyl)morpholine was evaluated for eye irritation potential in the in vitro EpiOcular eye irritation screening assay (MatTek Corporation; Ashland, MA). The EpiOcular tissue consists of normal, human-derived epidermal keratinocytes that are cultured to form a stratified, squamous epithelium similar to that found in the cornea. In this assay, 4-(3-(1-naphthylamino)propyl)morpholine was topically applied to the EpiOcular tissue for 30 ± 2 minutes, followed by approximately 120 minutes post-exposure recovery. Following recovery, the cell viability was measured in the treated and control tissues using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay and the data was reported as a percentage of the mean of negative control. Criteria for classification as an irritant (UN GHS Cat 1/2) or Non-Classified (UN GHS NC) was based on a cell viability of ≤60% or >60%, respectively. In this study, Dulbecco Phosphate Buffered Saline (DPBS) and 0.3% Triton X-100 served as the negative and positive controls, respectively. The percent viability for 4-(3-(1-naphthylamino)propyl)morpholine-treated EpiOcular tissue was 13.5% (i.e., ≤60%), therefore, 4-(3-(1-naphthylamino)propyl)morpholine was concluded to be a potential irritant (UN GHS Category 1/2).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.